Clinical trial
Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic…
NCT00141089 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00141089 |
|---|---|
| Title | Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. |
| Official title | Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Constipation |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 1,026 |
| Start date | Mar 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Feb 1, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: